TrialCancer immunology, immunotherapy : CII2019

A pilot study of interferon-alpha-2b dose reduction in the adjuvant therapy of high-risk melanoma.

Lorena P Suarez-Kelly et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.